A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis.

Limited clinical benefits derived from anti-VEGF therapy have driven the identification of new targets involved in tumor angiogenesis. Here, we report an integrative meta-analysis to define the transcriptional program underlying angiogenesis in human cancer. This approach identified ELTD1, an orphan...

Повний опис

Бібліографічні деталі
Автори:	Masiero, M, Simões, F, Han, H, Snell, C, Peterkin, T, Bridges, E, Mangala, L, Wu, S, Pradeep, S, Li, D, Han, C, Dalton, H, Lopez-Berestein, G, Tuynman, J, Mortensen, N, Li, J, Patient, R, Sood, A, Banham, A, Harris, A, Buffa, F
Формат:	Journal article
Мова:	English
Опубліковано:	Elsevier 2013

A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis за авторством Masiero, M, Simões, F, Han, H, Snell, C, Peterkin, T, Bridges, E, Mangala, L, Wu, S, Pradeep, S, Li, D, Han, C, Dalton, H, Lopez-Berestein, G, Tuynman, J, Mortensen, N, Li, J, Patient, R, Sood, A, Banham, A, Harris, A, Buffa, F

Опубліковано 2013

Journal article

A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis.

Схожі ресурси